NCT03893903: AMPLIFYing NEOepitope-specific VACcine Responses in Progressive Diffuse Glioma
- State
- Completed
- Phase
- Phase 1
- People
- 69 taking part
- Started
- 19 Oct 2018
- Primary completion
- 20 Sep 2024
- Arms
- IDH1 peptide vaccine
- Results
- None posted
- 19 Oct 2018: Trial started
- 28 Mar 2019: Trial registered
- 20 Sep 2024: Trial completed